S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN‐LABEL SOLACE‐KIDS TRIAL

Saved in:
Bibliographic Details
Published in:HemaSphere 2022-01, Vol.6 (Suppl), p.12-12
Main Authors: Heeney, M, Rees, D, Montalembert, M, Odame, I, Brown, C, Wali, Y, Nguyen, T, Lam, D, Pfender, N, Kanter, J
Format: Article
Language:English
Subjects:
Clinical and Epidemiological Studies
Oral Presentations
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000821456.11824.0b